Search results
Diabetic Blisters: A Symptom of Mismanaged Diabetes?
Verywell Health via Yahoo News· 2 days agoBlisters in diabetes have to do with skin changes from unregulated blood sugar levels. Find out how to manage blister symptoms on hands, feet, and legs.
Dexcom's blood sugar monitors now sync directly with your Apple Watch — here's why it's a big deal
Tom's Guide· 4 days agoWhile it would be a game-changer if the Apple Watch could read blood sugar levels on its own, users...
Rebound Hypoglycemia: Understanding Reactive Low Blood Sugar
Healthline· 4 days agoEating foods high in carbs can spike blood sugar levels. Rebound hypoglycemia occurs when blood ...
Ozempic and the length of time it stays in your system
Medical News Today· 2 days agoOzempic can stay in your system for several weeks. You may experience some effects if you stop...
POTS and Hypoglycemia: Are They Connected?
Healthline· 2 days agoPOTS can reduce your insulin sensitivity, which means it’s harder for your body to process blood sugar. While POTS is different from hypoglycemia, the &...
The 10 best low-sugar fruits that protect against chronic disease
The Telegraph via Yahoo News· 3 days agoAll fruits are good for you, there’s no disputing that, but some have a lower sugar content than...
Ozempic vs. metformin: What’s the difference?
Medical News Today· 6 days agoOzempic (semaglutide) is a brand-name drug, while metformin is a generic drug. This article explains the main similarities and differences between...
12 Celebrities Living With Diabetes
SheKnows via Yahoo News· 2 days agoIt shouldn’t come as a surprise that some of your favorite celebrities are among the over 29 million people across the country living with diabetes. ...
Essential signs of child type 2 diabetes all parents need to know
Rolling Out· 2 days agoChildhood type 2 diabetes is a growing concern worldwide. Unlike type 1 diabetes, which is often...
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients...
KOLR - KSFX Ozarks· 22 hours agoEli Lilly and Company (NYSE: LLY) announced detailed results from SYNERGY-NASH, a phase 2 study of 190 patients, with or without type 2 diabetes, to evaluate the investigational ...